These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16689136)

  • 1. Excitatory aminoacid neurotransmitters in schizophrenia.
    Morshed NM; Sobhan MA; Nahar JS; Keramat Ali SM; Shams M
    Bangladesh Med Res Counc Bull; 2005 Apr; 31(1):15-20. PubMed ID: 16689136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in serum amino acid concentrations in male and female schizophrenic patients.
    Tomiya M; Fukushima T; Watanabe H; Fukami G; Fujisaki M; Iyo M; Hashimoto K; Mitsuhashi S; Toyo'oka T
    Clin Chim Acta; 2007 May; 380(1-2):186-90. PubMed ID: 17367771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients--part II: adult subjects.
    Spivak B; Schechtman M; Schonherz-Pine Y; Blumensohn R; Mostovoy S; Amital D; Deckmann M; Weizman A; Shinitzky M
    Neuropsychobiology; 2009; 60(1):49-54. PubMed ID: 19729973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients.
    Raffa M; Mechri A; Othman LB; Fendri C; Gaha L; Kerkeni A
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1178-83. PubMed ID: 19576938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients.
    Akanji AO; Ohaeri JU; Al-Shammri S; Fatania HR
    Psychiatry Res; 2009 Aug; 169(1):56-61. PubMed ID: 19619902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: results from the Juntendo University Schizophrenia Projects (JUSP).
    Ohnuma T; Sakai Y; Maeshima H; Hatano T; Hanzawa R; Abe S; Kida S; Shibata N; Suzuki T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1905-12. PubMed ID: 18835577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia.
    Petronijević ND; Radonjić NV; Ivković MD; Marinković D; Piperski VD; Duricić BM; Paunović VR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1921-6. PubMed ID: 18824063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid neurotransmitters in alcohol withdrawal.
    Aliyev NA; Aliyev ZN; Aliguliyev AR
    Alcohol Alcohol; 1994 Nov; 29(6):643-7. PubMed ID: 7695778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics.
    Evins AE; Amico ET; Shih V; Goff DC
    J Neural Transm (Vienna); 1997; 104(6-7):761-6. PubMed ID: 9444574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of polymorphisms in the mitochondrial aspartate/glutamate carrier SLC25A12 (aralar) gene with schizophrenia.
    Hong CJ; Liou YJ; Liao DL; Hou SJ; Yen FC; Tsai SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1510-3. PubMed ID: 17693006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia -- Juntendo University Schizophrenia Projects (JUSP).
    Maeshima H; Ohnuma T; Sakai Y; Shibata N; Baba H; Ihara H; Higashi M; Ohkubo T; Nozawa E; Abe S; Ichikawa A; Nakano Y; Utsumi Y; Suzuki T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1410-8. PubMed ID: 17669570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine levels in newly admitted schizophrenic patients.
    Applebaum J; Shimon H; Sela BA; Belmaker RH; Levine J
    J Psychiatr Res; 2004; 38(4):413-6. PubMed ID: 15203293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal release of the amino acids with a time course in a rat model of postoperative pain.
    Wang Y; Yue Y; Shi L; Wu AS; Feng CS; Ni C
    Chin Med J (Engl); 2007 Nov; 120(22):1969-74. PubMed ID: 18067780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma dehydroepiandrosterone levels are strongly increased in schizophrenia.
    di Michele F; Caltagirone C; Bonaviri G; Romeo E; Spalletta G
    J Psychiatr Res; 2005 May; 39(3):267-73. PubMed ID: 15725425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia.
    Yilmaz N; Herken H; Cicek HK; Celik A; Yürekli M; Akyol O
    Med Princ Pract; 2007; 16(2):137-41. PubMed ID: 17303950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment.
    Sarandol A; Kirli S; Akkaya C; Altin A; Demirci M; Sarandol E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1164-9. PubMed ID: 17459548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum levels of glutamate in adult patients with autism.
    Shinohe A; Hashimoto K; Nakamura K; Tsujii M; Iwata Y; Tsuchiya KJ; Sekine Y; Suda S; Suzuki K; Sugihara G; Matsuzaki H; Minabe Y; Sugiyama T; Kawai M; Iyo M; Takei N; Mori N
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1472-7. PubMed ID: 16863675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects.
    Ritsner M; Maayan R; Gibel A; Weizman A
    Eur Neuropsychopharmacol; 2007 Apr; 17(5):358-65. PubMed ID: 17123790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced anticardiolipin antibodies in first episode and chronic schizophrenia.
    Sirota P; Bogdanov I; Katzav A; Hershko R; Chapman J
    Psychiatry Res; 2006 Nov; 144(2-3):211-6. PubMed ID: 16996617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.